Document Detail


Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix.
MedLine Citation:
PMID:  9062154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumor cells from eight freshly isolated cervical cancers (i.e., four adenocarcinomas and four squamous carcinomas) were analyzed for their production of the immune-inhibitory cytokine transforming growth factor-beta (TGF-beta) in vitro. All fresh adenocarcinomas secreted significant levels of TGF-beta (mean 397, range between 207 and 782 pg/ml/10(5) cells/48 hr). In contrast, no detectable TGF-beta was present in the supernatants from the four fresh squamous carcinoma cultures (P < 0.001). These data suggest that major differences in the secretion of the immunoinhibitory cytokine TGF-beta exist between squamous cell carcinomas and adenocarcinomas of the uterine cervix. Furthermore, these findings suggest that at least some of the differences in the natural biologic behavior, as well as in the response to radiation treatment, between these two histologic types of cervical cancer could be related to differences in secretion of this immune-inhibitory cytokine.
Authors:
A D Santin; P L Hermonat; J C Hiserodt; J Fruehauf; V Schranz; D Barclay; S Pecorelli; G P Parham
Related Documents :
16354594 - A population of hla-dr+ immature cells accumulates in the blood dendritic cell compartm...
17389194 - Large cell neuroendocrine carcinoma of the uterine cervix associated with adenocarcinoma.
16705014 - Distance-based clustering of cgh data.
11324934 - Cranial nerve palsy revealing an occipitovertebral metastasis from carcinoma of the ute...
1871214 - Glandular excision in total glandular mastectomy and modified radical mastectomy: a com...
17509724 - Interaction between cyp1a2-t2467delt polymorphism and smoking in adenocarcinoma and squ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Gynecologic oncology     Volume:  64     ISSN:  0090-8258     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  1997 Mar 
Date Detail:
Created Date:  1997-04-14     Completed Date:  1997-04-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  477-80     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Arkansas, Little Rock 72205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / secretion*
Carcinoma, Squamous Cell / secretion*
Female
Humans
Transforming Growth Factor beta / secretion*
Tumor Cells, Cultured
Uterine Neoplasms / secretion*
Chemical
Reg. No./Substance:
0/Transforming Growth Factor beta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA...
Next Document:  E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the c...